PMC5693911_01
PMC5693911_02
PMC5693911_03
Picture of our patient at the age of 27 years.
fendo-08-00309-g001.jpg
PMC5693911_03_fendo-08-00309-g001.jpg
F1
However, during examination she displayed an infantile appearance (149 cm, 43 kg), pale skin, puffy face, no axillary or pubic hair (Tanner AH1 and PH1, respectively), no breast development (Tanner B1-2), and with no history of a menstrual cycle (Figure 1).
PMC5693911_04
Magnetic resonance imaging of smaller pituitary gland.
fendo-08-00309-g002.jpg
PMC5693911_04_fendo-08-00309-g002.jpg
F2
MRI revealed a smaller but otherwise normal pituitary gland (Figure 2).
PMC5693911_05
PMC5693911_06
PMC5693911_07
Ultrasonography of uterus at the initiation of the treatment.
fendo-08-00309-g003.jpg
PMC5693911_07_fendo-08-00309-g003.jpg
F3
The titration of hormonal substitution therapy and findings from hormonal cytology and sonography of the uterus are presented in Table 2 and Figure 3.
PMC5693911_08